The general availability release of Reactor GenAI includes enhanced speech to text and file upload along with an improved interface and user experience.

China is rapidly advancing its brain-computer interface (BCI) technology, aiming to become a global leader in this field. A high-level committee has been established to set nationwide standards and guide BCI initiatives, positioning China to compete with Western companies like Elon Musk's Neuralink. BCIs, which translate brain signals into computer-readable data, have been researched since the 1970s and show promise in treating neurological conditions and aiding individuals with severe disabilities. China's ambitions extend beyond medical applications to potential cognitive enhancements, although details remain unclear. The global race for BCI supremacy is intensifying, with ethical and safety concerns being paramount. While Neuralink has achieved significant milestones with invasive procedures, other companies are exploring non-invasive alternatives. China's strategic moves, including setting nationwide standards, aim to streamline BCI development and foster innovation, making the future of BCI technology promising but ethically complex.